Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Phillips

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Applied and Environmental Microbiology|June 1, 1995
Fe(III) and S0 reduction by Pelobacter carbinolicusD R Lovley, E J Phillips, D J Lonergan, et al.
Applied and Environmental Microbiology|November 1, 1993
Reduction of uranium by cytochrome c3 of Desulfovibrio vulgarisD R Lovley, P K Widman, J C Woodward, et al.
HLA|November 25, 2017
HLAs: Key regulators of T-cell-mediated drug hypersensitivityA J Redwood, R K Pavlos, K D White, et al.
Applied and Environmental Microbiology|May 1, 1996
Isolation of Geobacter species from diverse sedimentary environmentsJ D Coates, E J Phillips, D J Lonergan, et al.
Environmental Microbiology|February 24, 2001
N2-dependent growth and nitrogenase activity in the metal-metabolizing bacteria, Geobacter and Magnetospirillum speciesD A Bazylinski, A J Dean, D Schüler, et al.
Brain, Behavior, and Immunity|January 7, 1998
The effect of exercise on lymphocyte redistribution and leucocyte function in asymptomatic HIV-infected subjectsE J Phillips, C A Ottaway, J Freedman, et al.
Journal of Bacteriology|April 1, 1996
Phylogenetic analysis of dissimilatory Fe(III)-reducing bacteriaD J Lonergan, H L Jenter, J D Coates, et al.
The British Journal of Dermatology|March 4, 2017
Recent advances in the understanding of severe cutaneous adverse reactionsN R Adler, A K Aung, E N Ergen, et al.
Archives of Microbiology|January 1, 1993
Geobacter metallireducens gen. nov. sp. nov., a microorganism capable of coupling the complete oxidation of organic compounds to the reduction of iron and other metalsD R Lovley, S J Giovannoni, D C White, et al.
Internal Medicine Journal|July 28, 2011
Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?M H Lee, S L Stocker, J Anderson, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Applied and Environmental Microbiology|June 1, 1995
Fe(III) and S0 reduction by Pelobacter carbinolicusD R Lovley, E J Phillips, D J Lonergan, et al.
Applied and Environmental Microbiology|November 1, 1993
Reduction of uranium by cytochrome c3 of Desulfovibrio vulgarisD R Lovley, P K Widman, J C Woodward, et al.
HLA|November 25, 2017
HLAs: Key regulators of T-cell-mediated drug hypersensitivityA J Redwood, R K Pavlos, K D White, et al.
Applied and Environmental Microbiology|May 1, 1996
Isolation of Geobacter species from diverse sedimentary environmentsJ D Coates, E J Phillips, D J Lonergan, et al.
Environmental Microbiology|February 24, 2001
N2-dependent growth and nitrogenase activity in the metal-metabolizing bacteria, Geobacter and Magnetospirillum speciesD A Bazylinski, A J Dean, D Schüler, et al.
Brain, Behavior, and Immunity|January 7, 1998
The effect of exercise on lymphocyte redistribution and leucocyte function in asymptomatic HIV-infected subjectsE J Phillips, C A Ottaway, J Freedman, et al.
Journal of Bacteriology|April 1, 1996
Phylogenetic analysis of dissimilatory Fe(III)-reducing bacteriaD J Lonergan, H L Jenter, J D Coates, et al.
The British Journal of Dermatology|March 4, 2017
Recent advances in the understanding of severe cutaneous adverse reactionsN R Adler, A K Aung, E N Ergen, et al.
Archives of Microbiology|January 1, 1993
Geobacter metallireducens gen. nov. sp. nov., a microorganism capable of coupling the complete oxidation of organic compounds to the reduction of iron and other metalsD R Lovley, S J Giovannoni, D C White, et al.
Internal Medicine Journal|July 28, 2011
Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?M H Lee, S L Stocker, J Anderson, et al.
Pageof 4